CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03799471
NCT03799471N/ACompleted

Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease

Dartmouth-Hitchcock Medical Center·observational·Posted Jan 10, 2019·Updated Aug 28, 2019

In Brief

An observational study for Inflammatory Bowel Diseases and 2 related conditions. Completed, enrolled 77 participants across 1 site.

Detailed Summary

This study evaluates nervous system hypersensitivity in individuals with inflammatory bowel disease (IBD) and experiences of ongoing musculoskeletal (MSK) pain. Previous results and current literature suggest that MSK pain in IBD may be influenced by hypersensitivity of the central nervous system, termed central sensitization. However, specific mechanisms contributing to pain experiences are unknown. Therefore, primary aims are to explore aspects of central sensitization through sensory testing in this population, and to investigate association of psychological and IBD features to sensory profiles. This study hypothesizes that IBD patients with MSK pain will demonstrate altered sensory function, and IBD/psychosocial features will be associated with altered sensory functioning and worse pain experiences.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsUniversity of Otago

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 10, 2019
Enrollment StartFeb 26, 2019
Primary CompletionJul 19, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.5 years ago